Provided by Tiger Trade Technology Pte. Ltd.

Cogent

23.63
+0.38001.63%
Post-market: 23.59-0.0387-0.16%19:26 EDT
Volume:805.80K
Turnover:18.93M
Market Cap:1.18B
PE:-6.22
High:23.85
Open:23.56
Low:23.06
Close:23.25
52wk High:56.89
52wk Low:15.96
Shares:50.06M
Float Shares:48.25M
Volume Ratio:0.88
T/O Rate:1.67%
Dividend:2.07
Dividend Rate:8.74%
EPS(TTM):-3.8009
EPS(LYR):-3.8009
ROE:-229.15%
ROA:-2.07%
PB:-18.53
PE(LYR):-6.22

Loading ...

Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire
·
Yesterday

Cogent to host first-quarter earnings call May 4

Reuters
·
Apr 15

Cogent Communications to See 'Soft' Q1, 'Strong Rebound' in H2, Oppenheimer Says

MT Newswires Live
·
Apr 08

Cogent Biosciences submits bezuclastinib new drug application to the FDA

TIPRANKS
·
Apr 01

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

GlobeNewswire
·
Apr 01

Cogent Biosciences Advances CGT6297 Into First-in-Human Trial for PIK3CA-Driven Cancers

TIPRANKS
·
Mar 28

Cogent Communications Holdings Inc. Announces Annual Stockholders Meeting

Reuters
·
Mar 21

Cogent Communications Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Mar 18

Cogent price target lowered to $22 from $23 at RBC Capital

TIPRANKS
·
Mar 18

RBC Lowers Price Target on Cogent Communications Holdings to $22 From $23, Keeps Sector Perform Rating

MT Newswires Live
·
Mar 18

Cogent Comms (CCOI) Gets a Hold from RBC Capital

TIPRANKS
·
Mar 18

Cogent Biosciences Coverage Assumed by Jefferies at Buy

Dow Jones
·
Mar 17

Cogent Biosciences assumed with a Buy at Jefferies

TIPRANKS
·
Mar 16

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

GlobeNewswire
·
Mar 16

Cogent CEO Dave Schaeffer to present at New Street x BCG Global Connectivity Leaders Conference

Reuters
·
Mar 13

Insider Shake-Up: Top Cogent Executives Quietly Cash Out Shares

TIPRANKS
·
Mar 06

Cogent Communications Director Sheryl Lynn Kennedy Reports Disposal of Common Shares

Reuters
·
Mar 06

Cogent Communications CFO Thaddeus Gerard Weed Disposes of Common Shares

Reuters
·
Mar 06

Cogent Communications Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Mar 06

U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva Systems

Reuters
·
Mar 05